MX2009003170A - Derivados de quinolina con propiedades de union a 5-hidroxitriptamina (5-ht). - Google Patents
Derivados de quinolina con propiedades de union a 5-hidroxitriptamina (5-ht).Info
- Publication number
- MX2009003170A MX2009003170A MX2009003170A MX2009003170A MX2009003170A MX 2009003170 A MX2009003170 A MX 2009003170A MX 2009003170 A MX2009003170 A MX 2009003170A MX 2009003170 A MX2009003170 A MX 2009003170A MX 2009003170 A MX2009003170 A MX 2009003170A
- Authority
- MX
- Mexico
- Prior art keywords
- lower alkyl
- ch2o
- binding properties
- quinoline derivatives
- ch2s
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 abstract 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Compuestos de la fórmula: (ver fórmula (I)) o sales farmacéuticamente aceptables de los mismos, en la que X es un enlace, -CH2CH2-, -CH=CH-, -CH2O-, -CH2NR-, -CH2S(O)-, -CH2S(O)2-, -O-, -OCH2CH2-, -S-, -SCH2-, -OCH2CH2S(O)-, -OCH2CH2S(O)2-, -CH2NRCO-, -CH2NRCH2-, (ver fórmula), -NRS(O) 2NR-, -NHCHR-, -NR- o -NRS(O)2-; y en la que X puede insertarse en ambas direcciónes dentro de la fórmula (I); Y en un enlace, -CHR- o -OCH2CH2-; R es hidrógeno o alquilo inferior; Ar1/Ar2 con independencia entre sí son arilo o heteroarilo de 5 a 10 miembros, opcionalmente sustituido por alquilo inferior, alcoxi inferior, haloalcoxi inferior, halógeno, -CF3, -CH2OH, -CH2O-alquilo inferior, cicloalquilo de 3 a 10 miembros, heterocicloalquilo de 5 a 10 miembros, -CH2O(CH2)2O-alquilo inferior, -S(O)2-alquilo inferior o -S(O)2NHR.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121449 | 2006-09-28 | ||
| PCT/EP2007/059840 WO2008037626A1 (en) | 2006-09-28 | 2007-09-18 | Quinoline derivatives with 5-ht-binding properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009003170A true MX2009003170A (es) | 2009-04-03 |
Family
ID=38925599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009003170A MX2009003170A (es) | 2006-09-28 | 2007-09-18 | Derivados de quinolina con propiedades de union a 5-hidroxitriptamina (5-ht). |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7825253B2 (es) |
| EP (1) | EP2076495B1 (es) |
| JP (1) | JP5111509B2 (es) |
| KR (1) | KR101088451B1 (es) |
| CN (1) | CN101516852B (es) |
| AR (1) | AR062994A1 (es) |
| AT (1) | ATE478050T1 (es) |
| AU (1) | AU2007302061B2 (es) |
| BR (1) | BRPI0717140A2 (es) |
| CA (1) | CA2664031A1 (es) |
| CL (1) | CL2007002768A1 (es) |
| DE (1) | DE602007008597D1 (es) |
| ES (1) | ES2347193T3 (es) |
| IL (1) | IL197301A0 (es) |
| MX (1) | MX2009003170A (es) |
| PE (1) | PE20080898A1 (es) |
| TW (1) | TW200819433A (es) |
| WO (1) | WO2008037626A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE477243T1 (de) | 2006-12-07 | 2010-08-15 | Hoffmann La Roche | 2-aminochinoline als 5-ht(5a)- rezeptorantagonisten |
| MX2010003001A (es) * | 2007-09-27 | 2010-04-01 | Hoffmann La Roche | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. |
| CA2715842A1 (en) | 2008-03-07 | 2009-09-11 | F. Hoffmann-La Roche Ag | 2-aminoquinoline derivatives |
| CA2717453A1 (en) | 2008-03-07 | 2009-09-11 | F. Hoffmann-La Roche Ag | 2-aminoquinolines |
| EP2254666A1 (en) * | 2008-03-12 | 2010-12-01 | F. Hoffmann-La Roche AG | 2-aminoquinolines as 5-ht5a receptor antagonists |
| AR116628A1 (es) | 2018-10-18 | 2021-05-26 | Syngenta Crop Protection Ag | Compuestos microbiocidas |
| GB201903942D0 (en) | 2019-03-22 | 2019-05-08 | Syngenta Crop Protection Ag | Microbiocidal compounds |
| US20230131427A1 (en) | 2020-03-05 | 2023-04-27 | Syngenta Crop Protection Ag | Fungicidal compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| SE0103649D0 (sv) | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| US7084156B2 (en) * | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| SE0202134D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| GB0309781D0 (en) | 2003-04-29 | 2003-06-04 | Glaxo Group Ltd | Compounds |
| GB0312609D0 (en) * | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| JP2005154434A (ja) * | 2003-11-05 | 2005-06-16 | Kyowa Hakko Kogyo Co Ltd | ２−アミノキナゾリン誘導体 |
-
2007
- 2007-09-18 CA CA002664031A patent/CA2664031A1/en not_active Abandoned
- 2007-09-18 MX MX2009003170A patent/MX2009003170A/es active IP Right Grant
- 2007-09-18 BR BRPI0717140-4A2A patent/BRPI0717140A2/pt not_active IP Right Cessation
- 2007-09-18 EP EP07803542A patent/EP2076495B1/en not_active Not-in-force
- 2007-09-18 ES ES07803542T patent/ES2347193T3/es active Active
- 2007-09-18 AT AT07803542T patent/ATE478050T1/de active
- 2007-09-18 WO PCT/EP2007/059840 patent/WO2008037626A1/en not_active Ceased
- 2007-09-18 JP JP2009529658A patent/JP5111509B2/ja not_active Expired - Fee Related
- 2007-09-18 KR KR1020097005608A patent/KR101088451B1/ko not_active Expired - Fee Related
- 2007-09-18 CN CN2007800353406A patent/CN101516852B/zh not_active Expired - Fee Related
- 2007-09-18 AU AU2007302061A patent/AU2007302061B2/en not_active Ceased
- 2007-09-18 DE DE602007008597T patent/DE602007008597D1/de active Active
- 2007-09-21 US US11/859,045 patent/US7825253B2/en not_active Expired - Fee Related
- 2007-09-26 CL CL200702768A patent/CL2007002768A1/es unknown
- 2007-09-26 AR ARP070104247A patent/AR062994A1/es unknown
- 2007-09-27 PE PE2007001313A patent/PE20080898A1/es not_active Application Discontinuation
- 2007-09-27 TW TW096135979A patent/TW200819433A/zh unknown
-
2009
- 2009-02-26 IL IL197301A patent/IL197301A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080081907A1 (en) | 2008-04-03 |
| US7825253B2 (en) | 2010-11-02 |
| KR20090042977A (ko) | 2009-05-04 |
| EP2076495A1 (en) | 2009-07-08 |
| ATE478050T1 (de) | 2010-09-15 |
| ES2347193T3 (es) | 2010-10-26 |
| AR062994A1 (es) | 2008-12-17 |
| KR101088451B1 (ko) | 2011-12-01 |
| CN101516852A (zh) | 2009-08-26 |
| TW200819433A (en) | 2008-05-01 |
| IL197301A0 (en) | 2009-12-24 |
| PE20080898A1 (es) | 2008-08-06 |
| CA2664031A1 (en) | 2008-04-03 |
| CL2007002768A1 (es) | 2008-04-18 |
| AU2007302061B2 (en) | 2012-01-19 |
| CN101516852B (zh) | 2011-11-16 |
| DE602007008597D1 (de) | 2010-09-30 |
| JP2010504939A (ja) | 2010-02-18 |
| JP5111509B2 (ja) | 2013-01-09 |
| WO2008037626A1 (en) | 2008-04-03 |
| BRPI0717140A2 (pt) | 2013-10-22 |
| AU2007302061A1 (en) | 2008-04-03 |
| EP2076495B1 (en) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003170A (es) | Derivados de quinolina con propiedades de union a 5-hidroxitriptamina (5-ht). | |
| MX2010003445A (es) | Derivados de nicotinamida, su preparacion y su uso terapeutico. | |
| MY160394A (en) | Novel phenol derivative | |
| EA201100763A1 (ru) | Методы получения хинолиновых производных | |
| AR088235A1 (es) | Derivados de pirazoloquinolina | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| GEP20156267B (en) | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES | |
| PH12015501813A1 (en) | Monocyclic pyridine derivative | |
| IN2014MN02106A (es) | ||
| TW200745070A (en) | Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use | |
| CO6341631A2 (es) | Derivados de 1,2,4 - oxadiazol y su uso terapéutico | |
| DOP2005000062A (es) | Derivados de la 1-amino-ftalazina, su preparacion y su aplicación en terapeutica | |
| MY168283A (en) | Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| AR067412A1 (es) | Moduladores de propiedades farmaceuticas de productos terapeuticos | |
| CO6241119A2 (es) | Compuestos de pirido 2,3-d pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cancer | |
| EP2581372A4 (en) | CYANOCHINOLINDERIVATE | |
| WO2007036532A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| WO2012044531A8 (en) | Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals | |
| WO2009095792A3 (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| AR073565A1 (es) | Derivados de bencimidazol, procesos de preparacion y composiciones farmaceuticas que los contienen | |
| HRP20050803B1 (hr) | Novitetna kristalna modifikacija anhidrata boskalida | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| AR096153A1 (es) | Derivados de pirrolo[2,3-d]pirimidina | |
| MX2012008147A (es) | Derivados de pirrazolopiridina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |